Cargando…

Differences in case-fatality-rate of emerging SARS-CoV-2 variants

OBJECTS: Variants of Severe-Acute-Respiratory-Syndrome Coronavirus-2 (SARS-CoV-2) has caused tremendous impact globally. It has been widely reported that the Omicron (B.1.1.529) variant is less deadly than the Delta (B.1.617.2) variant, presumably due to immunity from vaccination and previous infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Wei, Haozhen, He, Daihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741492/
https://www.ncbi.nlm.nih.gov/pubmed/36532099
http://dx.doi.org/10.1016/j.puhip.2022.100350
_version_ 1784848333885407232
author Liu, Jing
Wei, Haozhen
He, Daihai
author_facet Liu, Jing
Wei, Haozhen
He, Daihai
author_sort Liu, Jing
collection PubMed
description OBJECTS: Variants of Severe-Acute-Respiratory-Syndrome Coronavirus-2 (SARS-CoV-2) has caused tremendous impact globally. It has been widely reported that the Omicron (B.1.1.529) variant is less deadly than the Delta (B.1.617.2) variant, presumably due to immunity from vaccination and previous infection. When measuring the severity of a variant, Case-Fatality-Rate (CFR) is often estimated. The purpose of this work is to calculate the change in CFR of different variants over time from a large number of countries/regions since the start of the pandemic in 2020. STUDY DESIGN: A Cross-sectional study. METHODS: We extend the comparison to all previous VOCs in 58 counties/regions. We use reported death divided by reported cases in 30-day sliding window with a two-week shift between reported death and reported cases. RESULTS: The drop from Delta variant to Omicron variant is substantial and the difference between subvariants of Omicron is not evident. CONCLUSION: We showed that the CFR dropped over time, presumably due to vaccine-induced immune and infection induced immune. Population age structure and prevalence of comorbidity influence CFR.
format Online
Article
Text
id pubmed-9741492
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97414922022-12-12 Differences in case-fatality-rate of emerging SARS-CoV-2 variants Liu, Jing Wei, Haozhen He, Daihai Public Health Pract (Oxf) Original Research OBJECTS: Variants of Severe-Acute-Respiratory-Syndrome Coronavirus-2 (SARS-CoV-2) has caused tremendous impact globally. It has been widely reported that the Omicron (B.1.1.529) variant is less deadly than the Delta (B.1.617.2) variant, presumably due to immunity from vaccination and previous infection. When measuring the severity of a variant, Case-Fatality-Rate (CFR) is often estimated. The purpose of this work is to calculate the change in CFR of different variants over time from a large number of countries/regions since the start of the pandemic in 2020. STUDY DESIGN: A Cross-sectional study. METHODS: We extend the comparison to all previous VOCs in 58 counties/regions. We use reported death divided by reported cases in 30-day sliding window with a two-week shift between reported death and reported cases. RESULTS: The drop from Delta variant to Omicron variant is substantial and the difference between subvariants of Omicron is not evident. CONCLUSION: We showed that the CFR dropped over time, presumably due to vaccine-induced immune and infection induced immune. Population age structure and prevalence of comorbidity influence CFR. Elsevier 2022-12-10 /pmc/articles/PMC9741492/ /pubmed/36532099 http://dx.doi.org/10.1016/j.puhip.2022.100350 Text en © 2022 The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Liu, Jing
Wei, Haozhen
He, Daihai
Differences in case-fatality-rate of emerging SARS-CoV-2 variants
title Differences in case-fatality-rate of emerging SARS-CoV-2 variants
title_full Differences in case-fatality-rate of emerging SARS-CoV-2 variants
title_fullStr Differences in case-fatality-rate of emerging SARS-CoV-2 variants
title_full_unstemmed Differences in case-fatality-rate of emerging SARS-CoV-2 variants
title_short Differences in case-fatality-rate of emerging SARS-CoV-2 variants
title_sort differences in case-fatality-rate of emerging sars-cov-2 variants
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741492/
https://www.ncbi.nlm.nih.gov/pubmed/36532099
http://dx.doi.org/10.1016/j.puhip.2022.100350
work_keys_str_mv AT liujing differencesincasefatalityrateofemergingsarscov2variants
AT weihaozhen differencesincasefatalityrateofemergingsarscov2variants
AT hedaihai differencesincasefatalityrateofemergingsarscov2variants